Representative Josh Gottheimer (D-New Jersey) recently sold shares of Intuitive Surgical, Inc. NASDAQ: ISRG. In a filing disclosed on May 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in Intuitive Surgical stock on April 9th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account.
Representative Josh Gottheimer also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of RTX NYSE: RTX on 4/23/2025.
- Purchased $1,001 - $15,000 in shares of Cheniere Energy NYSE: LNG on 4/22/2025.
- Purchased $1,001 - $15,000 in shares of Techtronic Industries OTCMKTS: TTNDY on 4/21/2025.
- Purchased $1,001 - $15,000 in shares of Tri Pointe Homes NYSE: TPH on 4/21/2025.
- Purchased $1,001 - $15,000 in shares of Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk NYSE: TLK on 4/21/2025.
- Sold $1,001 - $15,000 in shares of KKR & Co. Inc. NYSE: KKR on 4/21/2025.
- Purchased $1,001 - $15,000 in shares of D.R. Horton NYSE: DHI on 4/21/2025.
- Purchased $1,001 - $15,000 in shares of Home Depot NYSE: HD on 4/21/2025.
- Sold $1,001 - $15,000 in shares of Hillman Solutions NASDAQ: HLMN on 4/17/2025.
- Sold $1,001 - $15,000 in shares of AbbVie NYSE: ABBV on 4/17/2025.
Intuitive Surgical Price Performance
Intuitive Surgical stock traded down $0.37 during midday trading on Wednesday, hitting $556.79. 431,033 shares of the stock were exchanged, compared to its average volume of 1,640,104. Intuitive Surgical, Inc. has a 1 year low of $396.15 and a 1 year high of $616.00. The firm has a market cap of $199.56 billion, a P/E ratio of 86.87, a P/E/G ratio of 5.85 and a beta of 1.70. The company has a 50 day moving average price of $508.11 and a two-hundred day moving average price of $537.36.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the previous year, the company earned $1.50 earnings per share. As a group, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Institutional Investors Weigh In On Intuitive Surgical
Hedge funds have recently made changes to their positions in the business. M.E. Allison & CO. Inc. acquired a new position in Intuitive Surgical during the 4th quarter worth $449,000. Seilern Investment Management Ltd bought a new position in Intuitive Surgical in the 4th quarter valued at about $82,517,000. Sycomore Asset Management increased its stake in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after buying an additional 4,079 shares during the period. China Universal Asset Management Co. Ltd. raised its position in shares of Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after buying an additional 525 shares in the last quarter. Finally, Brookstone Capital Management lifted its stake in shares of Intuitive Surgical by 25.4% in the 4th quarter. Brookstone Capital Management now owns 18,102 shares of the medical equipment provider's stock worth $9,448,000 after acquiring an additional 3,663 shares during the period. Institutional investors own 83.64% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on the company. Piper Sandler cut their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Truist Financial cut their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Jefferies Financial Group raised their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Raymond James increased their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Finally, Wells Fargo & Company boosted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a report on Friday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $598.95.
View Our Latest Stock Analysis on ISRG
Insider Activity
In other news, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares of the company's stock, valued at $2,793,033.06. The trade was a 60.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Fredrik Widman sold 810 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the sale, the vice president now directly owns 473 shares of the company's stock, valued at approximately $271,397.94. This represents a 63.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 32,700 shares of company stock worth $16,865,621 over the last three months. Corporate insiders own 0.70% of the company's stock.
About Representative Gottheimer
Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey's 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2027.
Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey's 5th Congressional District. He declared candidacy for the 2026 election.
Gottheimer is also running for election for Governor of New Jersey. He declared candidacy for the Democratic primary scheduled on June 10, 2025.
Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.
Intuitive Surgical Company Profile
(
Get Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report